% | $
Quotes you view appear here for quick access.

ONYX Pharmaceuticals, AŞ Message Board

  • dr.vinmantoo dr.vinmantoo Jun 21, 2013 11:55 AM Flag

    The imbecile troll osulinn is going wild.

    You would have to be a clueless imbecile or a lying short, and possibly both to say ONXX has cash flow or cash reserve problems. Even more hilarious is someone talking about revenues from 2 years ago, let alone to 6 months ago as if they were relevant. ONXX is flush with cash and revenues are dramatically increasing after the Kyprolis approval, and the rising usage of Stivarga.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • It's ironic that after the major selloff of the last two sessions, today early stage stocks such as ONXX, MDVN, and PCYC are doing much better than the more established biotechs such as GILD and CELG, which have only managed weak bounces today. Quite simply, I think, these are stocks which, if you sell them as the market deteriorates, you will quickly buy them back. It's actually dangerous not to be in them.